Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

Kara M. Kelly, Richard Sposto, Raymond Hutchinson, Vickie Massey, Kathleen McCarten, Sherrie Perkins, Mark Lones, Doojduen Villaluna, Michael Weiner

Blood (2011) 117 (9): 2596–2603.

https://doi.org/10.1182/blood-2010-05-285379

Published: 2011

Journal Articles

Remarkable Activity of Bortezomib Combined with Chemotherapy in a Phase I Study of Relapsed Childhood Acute Lymphoblastic Leukemia (ALL). A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Yoav H. Messinger, MD, Paul S. Gaynon, MD, Elizabeth Raetz, MD, Raymond Hutchinson, MD, MS, Steven DuBois, MD, Julia Glade Bender, MD, Richard Sposto, PhD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Bruce C. Bostrom, MD

Blood (2008) 112 (11): 1919.

https://doi.org/10.1182/blood.V112.11.1919.1919

Published: 2008

Journal Articles

Retrospective Survey of Children Treated for Relapsed Acute Lymphoblastic Leukemia (Complete Remission (CR) Rates): A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Richard H. Ko, MD, Lingyun Ji, MS, Richard Sposto, PhD, Phillip Barnette, MD, Bruce Bostrom, MD, Raymond Hutchinson, MD, Elizabeth Raetz, MD, Nita Seibel, MD, Clare Twist, MD, Elena Eckroth, BA, Paul Gaynon, MD, Mignon Loh, MD

Blood (2007) 110 (11): 854.

https://doi.org/10.1182/blood.V110.11.854.854

Published: 2007

Journal Articles

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group

Yousif Matloub, Susan Lindemulder, Paul S. Gaynon, Harland Sather, Mei La, Emmett Broxson, Rochelle Yanofsky, Raymond Hutchinson, Nyla A. Heerema, James Nachman, Marilyn Blake, Linda M. Wells, April D. Sorrell, Margaret Masterson, John F. Kelleher, Linda C. Stork

Blood (2006) 108 (4): 1165–1173.

https://doi.org/10.1182/blood-2005-12-011809

Published: 2006

Journal Articles

Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33 + acute myeloid leukemia

Robert J. Arceci, Jane Sande, Beverly Lange, Kevin Shannon, Janet Franklin, Raymond Hutchinson, Terry A. Vik, David Flowers, Richard Aplenc, Mark S. Berger, Matthew L. Sherman, Franklin O. Smith, Irwin Bernstein, Eric L. Sievers

Blood (2005) 106 (4): 1183–1188.

https://doi.org/10.1182/blood-2004-10-3821

Published: 2005

Journal Articles

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis: Presented in part at the American Society of Hematology Conference in Miami Beach, FL, December 1998.

Stanton C. Goldman, John S. Holcenberg, Jerry Z. Finklestein, Raymond Hutchinson, Susan Kreissman, F. Leonard Johnson, Conrad Tou, Elizabeth Harvey, Erin Morris, Mitchell S. Cairo

Blood (2001) 97 (10): 2998–3003.

https://doi.org/10.1182/blood.V97.10.2998

Published: 2001

Journal Articles

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Nyla A. Heerema, James B. Nachman, Harland N. Sather, Martha G. Sensel, Mei K. Lee, Raymond Hutchinson, Beverly J. Lange, Peter G. Steinherz, Bruce Bostrom, Paul S. Gaynon, Fatih Uckun

Blood (1999) 94 (12): 4036–4045.

https://doi.org/10.1182/blood.V94.12.4036

Published: 1999

Journal Articles

Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Cancer Group

Nyla A. Heerema, Harland N. Sather, Martha G. Sensel, Wen Liu-Mares, Beverly J. Lange, Bruce C. Bostrom, James B. Nachman, Peter G. Steinherz, Raymond Hutchinson, Paul S. Gaynon, Diane C. Arthur, Fatih M. Uckun

Blood (1999) 94 (5): 1537–1544.

https://doi.org/10.1182/blood.V94.5.1537

Published: 1999

NARROW

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

Remarkable Activity of Bortezomib Combined with Chemotherapy in a Phase I Study of Relapsed Childhood Acute Lymphoblastic Leukemia (ALL). A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Retrospective Survey of Children Treated for Relapsed Acute Lymphoblastic Leukemia (Complete Remission (CR) Rates): A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group

Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33 + acute myeloid leukemia

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis: Presented in part at the American Society of Hematology Conference in Miami Beach, FL, December 1998.

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Cancer Group

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only